Redmile Group, LLC - 10%+ Owner at ADC Therapeutics SA

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
ADCT on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Redmile Group, LLC in ADC Therapeutics SA

Buys

Open market
Shares
+7,692,306
Avg price
$3.90
Total value
+$29,999,993

Sells

Open market
Shares
-5,880,415
Avg price
$3.34
Total value
-$19,636,340

Net

Past year
Shares
+1,811,891
Share %
13%
Total value
+$10,363,653

Reported holdings for Redmile Group, LLC in ADC Therapeutics SA

Form 4 holding 10%+ Owner

ADC Therapeutics SA

Security class
Pre-Funded Warrants
Shares / value
3,846,153
Estimated value
$14,999,996
Report date
27 Oct 2025
Price
$3.90
Ownership
Direct
Underlying class
Common Share
Underlying amount
Form 4 holding 10%+ Owner

ADC Therapeutics SA

Security class
Pre-Funded Warrants
Shares / value
3,846,153
Estimated value
$14,999,996
Report date
27 Oct 2025
Price
$3.90
Ownership
Indirect
Underlying class
Common Share
Underlying amount

Transaction history for Redmile Group, LLC in ADC Therapeutics SA

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .